United States Healthcare Equipment & Supplies

Myomo Inc (MYO)

Track

Over the past 90 days, Myomo Inc. saw 16 insider transactions, resulting in a net positive value of approximately $285,539. While executives engaged in net selling, significant buying activity from other insiders offset these sales. These transactions follow the company's May 2026 earnings report, which showed an EPS miss of 5.81%.
Ticker: MYO Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Myomo Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 13 Jul 2026
Value US$1,329,019.59 | Price 227.13 | Shares 61,170
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-13 2026-07-13 PrS Proposed sale
1.6
David Henry

Officer

Officer
61,170
227.13
US$1,329,020 		61,170 227.13 US$1,329,020
2026-06-12 2026-06-12 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
15,826
236.05
US$1,425,876 		15,826 236.05 US$1,425,876
2026-06-12 2026-06-12 PrS Proposed sale
3.3
Micah Mitchell

Officer

Officer
25,553
229.10
US$2,489,615 		25,553 229.10 US$2,489,615
2026-06-08 2026-06-08 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
7,635
1.33
US$10,155 		7,635 1.33 US$10,155
2026-06-08 2026-06-08 PrS Proposed sale
3.3
Micah Mitchell

Officer

Officer
6,529
1.33
US$8,684 		6,529 1.33 US$8,684
2026-06-09 2026-06-05 B Purchase
2.6
KIRK THOMAS F
Non-Executive Director
40,002 +6.1%
1.27
US$50,803 		40,002 +6.1% 1.27 US$50,803
2026-06-01 2026-05-28 B Purchase
2.6
KIRK THOMAS F
Non-Executive Director
25,000 +4.0%
0.99
US$24,825 		25,000 +4.0% 0.99 US$24,825
2026-05-28 2026-05-28 S Sale
3.5
Kovelman Harry

Chief Medical Officer

Officer
11,536 -9.6%
1.02
US$11,734 		11,536 -9.6% 1.02 US$11,734
2026-05-28 2026-05-28 PrS Proposed sale
3.5
HARRY KOVELMAN

Officer

Officer
11,536
1.02
US$11,734 		11,536 1.02 US$11,734
2026-05-28 2026-05-27 S Sale
3.5
Kovelman Harry

Chief Medical Officer

Officer
20,464 -14.6%
1.00
US$20,505 		20,464 -14.6% 1.00 US$20,505
2026-05-27 2026-05-27 PrS Proposed sale
3.5
HARRY KOVELMAN

Officer

Officer
20,464
1.00
US$20,468 		20,464 1.00 US$20,468
2026-05-18 2026-05-18 B Purchase
2.6
KIRK THOMAS F
Non-Executive Director
43,401 +7.4%
0.91
US$39,495 		43,401 +7.4% 0.91 US$39,495
2026-05-18 2026-05-15 B Purchase
2.6
KIRK THOMAS F
Non-Executive Director
31,605 +5.7%
0.91
US$28,748 		31,605 +5.7% 0.91 US$28,748
2026-05-18 2026-05-15 B Purchase
2.6
Manko Joseph M. Jr.
Non-Executive Director
30,367 +1.3%
0.89
US$26,960 		30,367 +1.3% 0.89 US$26,960
2026-05-18 2026-05-14 B Purchase
2.6
Manko Joseph M. Jr.
Non-Executive Director
170,830 +8.1%
0.86
US$146,948 		170,830 +8.1% 0.86 US$146,948
2026-05-14 2026-05-14 PrS Proposed sale
3.3
MICAH MITCHELL

Officer

Officer
90,231
0.86
US$77,689 		90,231 0.86 US$77,689
2026-04-13 2026-04-13 PrS Proposed sale
1.6
David Henry

Officer

Officer
3,953
0.71
US$2,807 		3,953 0.71 US$2,807
2026-03-17 2026-03-16 B Purchase
3.5
Getz Heather C
Non-Executive Director
20,000 +17.9%
0.70
US$13,972 		20,000 +17.9% 0.70 US$13,972
2026-03-16 2026-03-13 B Purchase
2.6
KIRK THOMAS F
Non-Executive Director
72,000 +14.9%
0.71
US$51,113 		72,000 +14.9% 0.71 US$51,113
2026-03-12 2026-03-12 B Purchase
3.5
Getz Heather C
Non-Executive Director
70,000 +167.6%
0.73
US$50,960 		70,000 +167.6% 0.73 US$50,960
2025-11-24 2025-11-21 B Purchase
2.6
KIRK THOMAS F
Non-Executive Director
2,535 +0.5%
0.72
US$1,825 		2,535 +0.5% 0.72 US$1,825
2025-11-24 2025-11-20 B Purchase
2.6
KIRK THOMAS F
Non-Executive Director
4,902 +1.0%
0.72
US$3,529 		4,902 +1.0% 0.72 US$3,529
2025-11-21 2025-11-19 B Purchase
3.2
Crowley Thomas Aloysius Jr.
Non-Executive Director
385 +409.6%
0.77
US$295 		385 +409.6% 0.77 US$295
2025-11-21 2025-11-18 B Purchase
3.2
Crowley Thomas Aloysius Jr.
Non-Executive Director
4,000 +5.6%
0.73
US$2,938 		4,000 +5.6% 0.73 US$2,938
2025-08-26 2025-08-25 B Purchase
2.6
KIRK THOMAS F
Non-Executive Director
50,000 +11.8%
1.15
US$57,500 		50,000 +11.8% 1.15 US$57,500
2025-08-19 2025-08-18 B Purchase
2.6
KIRK THOMAS F
Non-Executive Director
50,000 +13.4%
1.10
US$55,000 		50,000 +13.4% 1.10 US$55,000
2025-08-18 2025-08-15 B Purchase
3.6
GUDONIS PAUL R

Chief Executive Officer

Executive Director
50,000 +4.1%
0.95
US$47,295 		50,000 +4.1% 0.95 US$47,295
2025-06-06 2025-06-06 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
5,743
2.97
US$17,057 		5,743 2.97 US$17,057
2025-06-06 2025-06-06 PrS Proposed sale
1.6
David Henry

Officer

Officer
8,373
2.97
US$24,868 		8,373 2.97 US$24,868
2025-05-15 2025-05-15 B Purchase
2.6
KIRK THOMAS F
Non-Executive Director
36,824 +12.0%
3.25
US$119,678 		36,824 +12.0% 3.25 US$119,678
2025-05-15 2025-05-15 B Purchase
3.6
GUDONIS PAUL R

Chief Executive Officer

Executive Director
30,000 +2.9%
3.22
US$96,612 		30,000 +2.9% 3.22 US$96,612
2026-05-15 2025-05-14 S Sale
3.3
Mitchell Micah

Chief Commercial Officer

Officer
90,231 -45.2%
0.86
US$77,689 		90,231 -45.2% 0.86 US$77,689
2025-05-15 2025-05-14 B Purchase
2.6
KIRK THOMAS F
Non-Executive Director
1,943 +0.6%
3.25
US$6,315 		1,943 +0.6% 3.25 US$6,315
2025-05-14 2025-05-12 B Purchase
2.6
KIRK THOMAS F
Non-Executive Director
50,000 +19.5%
3.35
US$167,500 		50,000 +19.5% 3.35 US$167,500
2025-03-14 2025-03-14 PrS Proposed sale
3.3
MICAH MITCHELL

Officer

Officer
48,000
5.16
US$247,565 		48,000 5.16 US$247,565
2025-03-14 2025-03-14 S Sale
3.3
Mitchell Micah

Chief Commercial Officer

Officer
48,000 -25.5%
5.16
US$247,565 		48,000 -25.5% 5.16 US$247,565
2025-03-14 2025-03-13 B Purchase
2.6
KIRK THOMAS F
Non-Executive Director
7,400 +3.0%
5.00
US$37,000 		7,400 +3.0% 5.00 US$37,000
2025-03-13 2025-03-13 PrS Proposed sale
3.3
Micah Mitchell

Officer

Officer
1,283
5.22
US$6,697 		1,283 5.22 US$6,697
2025-03-13 2025-03-13 PrS Proposed sale
1.6
David Henry

Officer

Officer
2,019
5.22
US$10,539 		2,019 5.22 US$10,539
2025-03-13 2025-03-13 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
1,496
5.22
US$7,809 		1,496 5.22 US$7,809
2025-03-13 2025-03-12 S Sale
3.5
Kovelman Harry

Chief Medical Officer

Officer
30,000 -23.4%
5.50
US$165,018 		30,000 -23.4% 5.50 US$165,018
2025-03-12 2025-03-12 PrS Proposed sale
3.5
HARRY KOVELMAN

Officer

Officer
30,000
5.50
US$165,015 		30,000 5.50 US$165,015
2024-11-04 2024-11-04 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
121
3.70
US$448 		121 3.70 US$448
2024-10-03 2024-10-03 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
121
3.86
US$467 		121 3.86 US$467
2024-09-09 2024-09-05 S Sale
3.5
Kovelman Harry

Chief Medical Officer

Officer
6,700 -5.1%
3.76
US$25,183 		6,700 -5.1% 3.76 US$25,183
2024-09-04 2024-09-04 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
139
3.89
US$541 		139 3.89 US$541
2024-09-05 2024-09-03 S Sale
3.5
Kovelman Harry

Chief Medical Officer

Officer
2,029 -1.5%
4.01
US$8,140 		2,029 -1.5% 4.01 US$8,140
2024-09-03 2024-09-03 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
18,500
4.00
US$74,000 		18,500 4.00 US$74,000
2024-08-05 2024-08-05 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
128
3.96
US$507 		128 3.96 US$507
2024-07-03 2024-07-03 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
121
2.85
US$345 		121 2.85 US$345
2024-07-01 2024-07-01 PrS Proposed sale
1.6
David Henry

Officer

Officer
25,436
3.02
US$76,817 		25,436 3.02 US$76,817
2024-07-01 2024-07-01 PrS Proposed sale
3.3
Micah Mitchell

Officer

Officer
15,500
3.02
US$46,810 		15,500 3.02 US$46,810
2024-07-01 2024-07-01 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
12,868
3.02
US$38,861 		12,868 3.02 US$38,861
2024-06-10 2024-06-10 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
5,340
3.39
US$18,103 		5,340 3.39 US$18,103
2024-06-10 2024-06-10 PrS Proposed sale
3.3
Micah Mitchell

Officer

Officer
6,824
3.39
US$23,133 		6,824 3.39 US$23,133
2024-06-10 2024-06-10 PrS Proposed sale
1.6
David Henry

Officer

Officer
10,599
3.39
US$35,931 		10,599 3.39 US$35,931
2024-06-03 2024-06-03 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
121
3.41
US$413 		121 3.41 US$413
2024-05-31 2024-05-29 B Purchase
2.6
KIRK THOMAS F
Non-Executive Director
50,000 +26.8%
3.50
US$175,000 		50,000 +26.8% 3.50 US$175,000
2024-05-17 2024-05-15 S Sale
3.5
Kovelman Harry

Chief Medical Officer

Officer
35,426 -26.5%
3.69
US$130,839 		35,426 -26.5% 3.69 US$130,839
2024-05-15 2024-05-15 PrS Proposed sale
3.5
HARRY KOVELMAN

Officer

Officer
35,426
3.69
US$130,835 		35,426 3.69 US$130,835
2024-05-03 2024-05-03 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
146
3.92
US$572 		146 3.92 US$572
2024-04-02 2024-04-03 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
146
3.03
US$442 		146 3.03 US$442
2024-03-18 2024-03-14 B Purchase
2.6
KIRK THOMAS F
Non-Executive Director
50,000 +36.6%
3.50
US$175,000 		50,000 +36.6% 3.50 US$175,000
2024-03-11 2024-03-11 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
6,590
3.19
US$21,022 		6,590 3.19 US$21,022
2024-03-11 2024-03-11 PrS Proposed sale
1.6
David Henry

Officer

Officer
7,774
3.19
US$24,799 		7,774 3.19 US$24,799
2024-03-11 2024-03-11 PrS Proposed sale
3.3
Micah Mitchell

Officer

Officer
5,359
3.19
US$17,095 		5,359 3.19 US$17,095
2024-03-04 2024-03-04 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
151
3.86
US$583 		151 3.86 US$583
2024-02-02 2024-02-05 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
146
3.40
US$496 		146 3.40 US$496
2024-01-02 2024-01-03 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
145
4.79
US$695 		145 4.79 US$695
2023-12-08 2023-12-08 PrS Proposed sale
3.2
THOMAS CROWLEY JR

Director

Non-Executive Director
14,997
4.18
US$62,635 		14,997 4.18 US$62,635
2023-12-08 2023-12-08 S Sale
3.2
Crowley Thomas Aloysius Jr.
Non-Executive Director
14,997
0.00
US$0 		14,997 0.00 US$0
2023-12-04 2023-12-05 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
99
4.07
US$403 		99 4.07 US$403
2023-12-05 2023-12-01 S Sale
3.5
Kovelman Harry

Chief Medical Officer

Officer
8,333
0.00
US$0 		8,333 0.00 US$0
2023-12-04 2023-12-01 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
8,333
3.12
US$25,999 		8,333 3.12 US$25,999
2023-11-30 2023-11-28 S Sale
3.2
Crowley Thomas Aloysius Jr.
Non-Executive Director
14,997
0.00
US$0 		14,997 0.00 US$0
Explore more

More insider trading research around Myomo Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America